- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Idera Pharmaceuticals Inc+ Add to Watchlist
IDRA:US2.2100 USD 0.0800 3.49%
As of 11:42:49 ET on 10/01/2014.
Company Profile for Idera Pharmaceuticals Inc (IDRA)
Idera Pharmaceuticals, Inc. is a biotechnology company. The Company develops therapeutics that modulate the immune response through Toll-like receptors. Idera is working on therapeutics for oncology, asthma/allergy, and infectious diseases.
Idera Pharmaceuticals Inc
Key Executives for Idera Pharmaceuticals Inc (IDRA)
|Sudhir D Agrawal "Phil"President/CEO||Louis J Arcudi IIISenior VP/CFO/Treasurer/Secy|
|Louis BrennerSenior VP/Chief Medical Ofcr||Robert D ArbeitVP:Clinical Development|
|Nancy WyantVP:Clinical Operations||Timothy M SullivanVP:Dev Programs & Alliance|
|Kathryn HavilandVP:Rare Diseases|